Randomized phase II trial of autologous dendritic cells loaded with autologous tumor cell antigens from self-renewing cancer cells in patients with newly diagnosed stage III or IV ovarian cancer

被引：0
|
作者：
Abaid, Lisa [1 ]
Friedman, Richard [2 ]
Brown, John [1 ]
Mendivil, Alberto [1 ]
Beck, Tiffany [1 ]
Corr, Bradley [3 ]
Randall, Leslie [4 ]
Mason, James [5 ]
Hsieh, Candace [6 ]
Nistor, Gabriel [6 ]
Dillman, Robert [6 ]
机构：
[1] Hoag Hosp, Newport Beach, CA USA
[2] Disney Family Canc Ctr, Burbank, CA USA
[3] Univ Colorado, Aurora, CO USA
[4] Univ Calif Irvine, Orange, CA 92668 USA
[5] Scripps Green & Mem Hosp, La Jolla, CA USA
[6] AiVita Biomed Inc, Irvine, CA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P391
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PHASE II TRIAL OF AV-GBM-1: DENDRITIC CELL VACCINE PULSED WITH LYSATE ENRICHED FOR AUTOLOGOUS TUMOR-INITIATING CELL ANTIGENS IN THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Bota, Daniela
    Piccioni, David
    Duma, Christopher
    LaRocca, Renato
    Kesari, Santosh
    Abedi, Mehrdad
    Carrillo, Jose
    Aiken, Robert
    Hsu, Frank
    Kong, Xiaotang
    Taylor, Thomas
    Hsieh, Candace
    Nistor, Gabriel
    Dillman, Robert
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A1001 - A1001
  • [32] A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
    Kandalaft, Lana E.
    Chiang, Cheryl L.
    Tanyi, Janos
    Motz, Greg
    Balint, Klara
    Mick, Rosemarie
    Coukos, George
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [33] A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
    Lana E Kandalaft
    Cheryl L Chiang
    Janos Tanyi
    Greg Motz
    Klara Balint
    Rosemarie Mick
    George Coukos
    Journal of Translational Medicine, 11
  • [34] Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer
    Mayordomo, Jose Ignacio
    Andres, Raquel
    Isla, Maria Dolores
    Murillo, Laura
    Cajal, Rosana
    Yubero, Alfonso
    Blasco, Carmen
    Lasierra, Pilar
    Palomera, Luis
    Fuertes, Miguel Angel
    Guemes, Antonio
    Sousa, Ramon
    Garcia-Prats, Maria Dolores
    Escudero, Pilar
    Saenz, Alberto
    Godino, Javier
    Marco, Ivan
    Saez, Berta
    Visus, Carmen
    Asin, Laura
    Valdivia, Gabriel
    Larrad, Luis
    Tres, Alejandro
    TUMORI, 2007, 93 (01) : 26 - 30
  • [35] A PHASE I, II TRIAL OF AUTOLOGOUS DENDRITIC CELL TUMOR VACCINE COMBINED WITH IRRADIATION PATIENTS WITH REFRACTORY METASTATIC COLORECTAL CANCER
    Choi, Y. J.
    Seol, Y. M.
    Kim, H. J.
    Chung, J. S.
    Cho, G. J.
    ANNALS OF ONCOLOGY, 2012, 23 : 172 - 172
  • [36] A randomized controlled phase II clinical trial on mRNA electroporated autologous dendritic cells for stage III/IV melanoma patients who are disease-free following the local treatment of macrometastases
    Neyns, Bart
    Jansen, Yanina
    Corthals, Jurgen
    Wilgenhof, Sofie
    Schreuer, Max
    Heirman, Carlo
    Thielemans, Kris
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [37] ADVERSE EVENTS IN A PHASE II TRIAL OF AV-GBM-1: DENDRITIC CELL VACCINE PULSED WITH LYSATE ENRICHED FOR AUTOLOGOUS TUMOR-INITIATING CELL ANTIGENS FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Piccioni, David
    Piccioni, David
    Bota, Daniela
    LaRocca, Renato
    Kesari, Santosh
    Carillo, Jose
    Kong, Xiao-Tang
    Duma, Christopher
    Abedi, Mehrdad
    Aiken, Robert
    Taylor, Thomas
    Hsieh, Candace
    Nistor, Gabriel
    Dillman, Robert
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A362 - A362
  • [38] Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)
    Ridolfi, Laura
    de Rosa, Francesco
    Fiammenghi, Laura
    Petrini, Massimiliano
    Granato, Anna Maria
    Ancarani, Valentina
    Pancisi, Elena
    Soldati, Valentina
    Cassan, Serena
    Bulgarelli, Jenny
    Riccobon, Angela
    Gentili, Giorgia
    Nanni, Oriana
    Framarini, Massimo
    Tauceri, Francesca
    Guidoboni, Massimo
    BMJ OPEN, 2018, 8 (08):
  • [39] A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
    Inoges, Susana
    Tejada, Sonia
    de Cerio, Ascension Lopez-Diaz
    Perez-Larraya, Jaime Gallego
    Espinos, Jaime
    Idoate, Miguel Angel
    Dominguez, Pablo Daniel
    de Eulate, Reyes Garcia
    Aristu, Javier
    Bendandi, Maurizio
    Pastor, Fernando
    Alonso, Marta
    Andreu, Enrique
    Cardoso, Felipe Prosper
    Valle, Ricardo Diez
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [40] PROLIFERATIVE RESPONSE OF LYMPHOCYTES FROM OVARIAN-CANCER PATIENTS TO AUTOLOGOUS TUMOR-CELLS
    ALLAVENA, P
    LOPRESTI, P
    DIBELLO, M
    LUCCHINI, V
    LISSONI, A
    ZANETTA, G
    MANGIONI, C
    MANTOVANI, A
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1988, 27 (01) : 69 - 76
12345